Michael P. Dube
VP, Chief Accounting Officer at Intellia Therapeutics · 6 reported transactions in 1 company · latest trade Oct 2, 2026
Their trades
Sold | Oct 2, 2026 | Oct 2, 2026 close $12.26 → Oct 28, 2026 close $13.32. S&P 500 +0.0% over the same days. | ||
Sold | Jul 1, 2026 | Jul 1, 2026 close $17.24 → Oct 28, 2026 close $13.32. S&P 500 +3.2% over the same days. | ||
Sold | Jan 5, 2026 | Jan 5, 2026 close $9.37 → Oct 28, 2026 close $13.32. S&P 500 +11.9% over the same days. | ||
Sold | Oct 1, 2025 | Oct 1, 2025 close $18.76 → Oct 28, 2026 close $13.32. S&P 500 +15.1% over the same days. | ||
Sold | Jul 2, 2025 | Jul 2, 2025 close $10.73 → Oct 28, 2026 close $13.32. S&P 500 +24.1% over the same days. |
$23.2K
Oct 2, 2026 close $12.26 → Oct 28, 2026 close $13.32. S&P 500 +0.0% over the same days.
$44.3K
Jul 1, 2026 close $17.24 → Oct 28, 2026 close $13.32. S&P 500 +3.2% over the same days.
$27.5K
Jan 5, 2026 close $9.37 → Oct 28, 2026 close $13.32. S&P 500 +11.9% over the same days.
$32.5K
Oct 1, 2025 close $18.76 → Oct 28, 2026 close $13.32. S&P 500 +15.1% over the same days.
$24.9K
Jul 2, 2025 close $10.73 → Oct 28, 2026 close $13.32. S&P 500 +24.1% over the same days.